In vitro phenotypic effects of Lipoxin A4 on M1 and M2 polarized macrophages derived from THP-1

Background Lipoxin A4 (LXA4) is a specialized pro-resolving mediator involved in the resolution phase of inflammation that is crucial for the return of tissues to homeostasis, healing, and regenerative processes. LXA4 can modify the microenvironment via its receptor, formyl peptide receptor 2 (FPR2) and thus modulate the inflammatory response. However, the effect of exogeneous LXA4 application on polarized macrophages remains unstudied. The objective of this study was to assess the effect of LXA4 on macrophage activity and on the phenotype modulation of polarized M1 and M2 macrophages derived from THP-1 monocytes. Methods and results Once differentiated, human macrophages were incubated with interleukin 4 (IL-4) and IL-13 to obtain M2-polarized macrophages or with interferon gamma and lipopolysaccharide for classical macrophage activation. The mRNA and protein expression of M1 and M2 markers confirmed the polarization of THP-1-derived macrophages. LXA4 (0-100 nM) did not affect the viability of M1 and M2 macrophages or the phagocytic activity of these cells. Gene expression of FPR2, referred as a receptor for the LXA4, was higher in M1 compared with M2, and was not modified by the LXA4 at the doses used. Moreover, LXA4 exhibited anti-inflammatory properties illustrated by the decreasing in the gene expression of pro-inflammatory cytokines (IL-6, tumor necrosis factor alpha, IL-1 beta) in M1 and by the increase in the expression of anti-inflammatory cytokines (IL-10) in M2 macrophages. Conclusions These results provide new insights regarding the potential of LXA4 to regulate the polarization state of macrophages.

Automated summary

This study evaluated the effect of LXA4 on macrophage activity and phenotype modulation of polarized M1 and M2 macrophages. The results showed that LXA4 did not affect the viability and phagocytic activity of macrophages, but exhibited anti-inflammatory properties by reducing pro-inflammatory cytokine expression in M1 and increasing anti-inflammatory cytokine expression in M2 macrophages.